Get the Stockscreener App
0.8853
0.86%
-0.0077
Hookipa Pharma Inc stock is traded at $0.8853, with a volume of 28,041.
It is down -0.86% in the last 24 hours and down -29.18% over the past month.
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.
See More
Previous Close:
$0.893
Open:
$0.87
24h Volume:
28,041
Relative Volume:
0.19
Market Cap:
$8.68M
Revenue:
$52.16M
Net Income/Loss:
$-48.60M
P/E Ratio:
-0.2049
EPS:
-4.32
Net Cash Flow:
$-77.48M
1W Performance:
-3.77%
1M Performance:
-29.18%
6M Performance:
-54.83%
1Y Performance:
-83.87%
1-Day Range:
$0.8613
$0.898
1-Week Range:
$0.8613
$0.95
52-Week Range:
$0.721
$5.66
Hookipa Pharma Inc Stock (HOOK) Company Profile
Name
Hookipa Pharma Inc
Sector
Industry
Phone
0114318906360
Address
350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240, NEW YORK, NY
Compare HOOK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOOK
Hookipa Pharma Inc
|
0.8853 | 10.89M | 52.16M | -48.60M | -77.48M | -4.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Hookipa Pharma Inc Stock (HOOK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-15-24 | Reiterated | RBC Capital Mkts | Outperform |
| Dec-02-22 | Downgrade | BofA Securities | Buy → Underperform |
| Nov-12-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-08-21 | Initiated | Morgan Stanley | Overweight |
| Nov-03-20 | Initiated | Truist | Buy |
| Oct-26-20 | Initiated | JMP Securities | Mkt Outperform |
| Oct-19-20 | Resumed | H.C. Wainwright | Buy |
| Sep-27-19 | Initiated | H.C. Wainwright | Buy |
| May-13-19 | Initiated | BofA/Merrill | Buy |
| May-13-19 | Initiated | RBC Capital Mkts | Outperform |
View All
Hookipa Pharma Inc Stock (HOOK) Latest News
What institutional investors are buying HOOKIPA Pharma Inc. stockStock Market Ideas With Proven Results - jammulinksnews.com
Visual trend scoring systems applied to HOOKIPA Pharma Inc.Breakout Watcher with Entry and Exit Alerts - Newser
Can trapped investors hope for a rebound in HOOKIPA Pharma Inc.Trade Ideas Based on Fundamental Metrics - Newser
What makes HOOKIPA Pharma Inc. stock price move sharplyBuy and Hold Strategy for Capital Safety - Newser
Does HOOKIPA Pharma Inc. stock pay reliable dividendsFree Trend Following Strategy With Stop Loss - Newser
How hedge fund analytics apply to HOOKIPA Pharma Inc. stockGrowth Projection Summary for Long-Term Investors - Newser
How many analysts rate HOOKIPA Pharma Inc. as a “Buy”Chart Pattern Guidance To Watch Now - jammulinksnews.com
Analyzing recovery setups for HOOKIPA Pharma Inc. investorsFree Weekly Hot Picks With Buy Confidence - Newser
How volatile is HOOKIPA Pharma Inc. stock compared to the marketWealth Building Review With Proven Results - jammulinksnews.com
Using data tools to time your HOOKIPA Pharma Inc. exitShort-Term Sector Movement Forecast Generator - Newser
Is HOOKIPA Pharma Inc. a candidate for recovery playShort-Term Growth Watch with Signal Prediction - Newser
HOOKIPA Pharma Inc. Earnings Report Breakdown: What Investors Should KnowFree Alpha Focused Technical Trade Signals - Newser
How Efficient Is HOOKIPA Pharma Inc. at Controlling Operating CostsHigh Confidence Strategy with Trend Alignment - Newser
Hookipa Pharma Approves Asset Sale and Liquidation - TipRanks
Is HOOKIPA Pharma Inc. the Top Chart Pick This WeekTriple Digit Growth Focused Trade Plan Reviewed - metal.it
Is HOOKIPA Pharma Inc. Stock a Good Fit for Conservative InvestorsFree Triple Digit Growth Focused Trade Plan - Newser
Will HOOKIPA Pharma Inc. stock benefit from interest rate changesRisk-Managed Strategy Based on Price Analysis - Newser
What is HOOKIPA Pharma Inc. company’s growth strategyStock Market Opportunities For Every Investor - jammulinksnews.com
RSI Reset May Fuel Rebound in HOOKIPA Pharma Inc.Day Trading Signals With High Precision Reviewed - metal.it
HOOKIPA Pharma Inc. Earnings Report Breakdown: What Investors Should Know Momentum Detection with Entry Optimization - Newser
How Interest Rate Changes Impact HOOKIPA Pharma Inc. Stock Performance Fast Movement Forecast for Trading Success - Newser
What catalysts could drive HOOKIPA Pharma Inc. stock higher in 2025Explosive wealth accumulation - jammulinksnews.com
Is HOOKIPA Pharma Inc. stock overvalued or undervaluedInvest smarter with expert stock picks - jammulinksnews.com
Is HOOKIPA Pharma Inc. a growth stock or a value stockStay informed with expert market forecasts - jammulinksnews.com
What is the risk reward ratio of investing in HOOKIPA Pharma Inc. stockUnlock powerful stock screening tools today - jammulinksnews.com
Does HOOKIPA Pharma Inc. stock perform well during market downturnsExceptional market performance - jammulinksnews.com
Competitive Positioning of HOOKIPA Pharma Inc.: Is It Leading or LaggingTrade Ready Signal - Newser
How Interest Rate Changes Impact HOOKIPA Pharma Inc. Stock PerformanceEquity Portfolio Outlook and Performance Summary - Newser
What analysts say about HOOKIPA Pharma Inc. stockExponential wealth increase - PrintWeekIndia
Is HOOKIPA Pharma Inc. a good long term investmentFree Investment Portfolio Suggestions - PrintWeekIndia
What drives HOOKIPA Pharma Inc. stock priceHigh-yield portfolio picks - PrintWeekIndia
Hookipa Pharma Inc Stock (HOOK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Hookipa Pharma Inc Stock (HOOK) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Coelho Mary Theresa | EVP and CFO |
Jul 22 '25 |
Sale |
0.92 |
13,609 |
12,520 |
56,266 |
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):